Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Indivior Inc.
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subjects who received at least one injection in RBP-6000 or placebo in the Phase III clinical program which includes study protocols NCT02357901 (RB-US-13-0001) and NCT02510014 (RB-US-13-0003) and either withdrew from or completed these studies.
Ability to comply with study protocol requirements for data collection and provide informed consent.
Clareo Health | An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
